Skip to main content
Top
Published in: BMC Gastroenterology 1/2011

Open Access 01-12-2011 | Research article

The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population

Authors: Elaine Toy, Sripriya Balasubramanian, Carlo Selmi, Chin-Shang Li, Christopher L Bowlus

Published in: BMC Gastroenterology | Issue 1/2011

Login to get access

Abstract

Background

Primary sclerosing cholangitis (PSC) is a rare chronic cholestatic liver disease often associated with inflammatory bowel diseases (IBD). Current epidemiological data are limited to studies of predominantly Caucasian populations. Our aim was to define the epidemiology of PSC in a large, ethnically diverse US population.

Methods

The Northern California Kaiser Permanente (KP) database includes records from over 3 million people and was searched for cases of PSC between January 2000 and October 2006. All identified charts were reviewed for diagnosis confirmation, IBD co-morbidity, and major natural history endpoints.

Results

We identified 169 (101 males) cases fulfilling PSC diagnostic criteria with a mean age at diagnosis of 44 years (range 11-81). The age-adjusted point prevalence was 4.15 per 100,000 on December 31, 2005. The age-adjusted incidence per 100,000 person-years was not significantly greater in men 0.45 (95% CI 0.33 - 0.61) than women 0.37 (95% CI 0.26 - 0.51). IBD was present in 109/169 (64.5%) cases and was significantly more frequent in men than women with PSC (73.3% and 51.5%, respectively, p = 0.005). The cumulative average yearly mortality rate was 1.9%. Age and serum sodium, creatinine and bilirubin at diagnosis and albumin at last entry were identified as significant factors associated with death, liver transplant or cholangiocarcinoma.

Conclusions

The incidence and prevalence of PSC observed in a representative Northern California population are lower compared to previous studies in Caucasian populations and this might reflect differences in the incidence of PSC among various ethnic groups.
Appendix
Available only for authorised users
Literature
1.
go back to reference Aoki CA, Bowlus CL, Gershwin ME: The immunobiology of primary sclerosing cholangitis. Autoimmun Rev. 2005, 4 (3): 137-143. 10.1016/j.autrev.2004.09.003.CrossRefPubMed Aoki CA, Bowlus CL, Gershwin ME: The immunobiology of primary sclerosing cholangitis. Autoimmun Rev. 2005, 4 (3): 137-143. 10.1016/j.autrev.2004.09.003.CrossRefPubMed
2.
go back to reference EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009, 51 (2): 237-267. 10.1016/j.jhep.2009.04.009. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009, 51 (2): 237-267. 10.1016/j.jhep.2009.04.009.
3.
go back to reference Faubion WA, Loftus EV, Sandborn WJ, Freese DK, Perrault J: Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with psc. J Pediatr Gastroenterol Nutr. 2001, 33 (3): 296-300. 10.1097/00005176-200109000-00013.CrossRefPubMed Faubion WA, Loftus EV, Sandborn WJ, Freese DK, Perrault J: Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with psc. J Pediatr Gastroenterol Nutr. 2001, 33 (3): 296-300. 10.1097/00005176-200109000-00013.CrossRefPubMed
4.
go back to reference Loftus EV, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, Jewell DA, Sandborn WJ: PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005, 54 (1): 91-96. 10.1136/gut.2004.046615.CrossRefPubMedPubMedCentral Loftus EV, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, Jewell DA, Sandborn WJ: PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005, 54 (1): 91-96. 10.1136/gut.2004.046615.CrossRefPubMedPubMedCentral
5.
go back to reference Loftus EV, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton LJ: Primary sclerosing cholangitis is associated with nonsmoking: a case-control study. Gastroenterology. 1996, 110 (5): 1496-1502. 10.1053/gast.1996.v110.pm8613055.CrossRefPubMed Loftus EV, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton LJ: Primary sclerosing cholangitis is associated with nonsmoking: a case-control study. Gastroenterology. 1996, 110 (5): 1496-1502. 10.1053/gast.1996.v110.pm8613055.CrossRefPubMed
6.
go back to reference Mitchell SA, Thyssen M, Orchard TR, Jewell DP, Fleming KA, Chapman RW: Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study. Gut. 2002, 51 (4): 567-573. 10.1136/gut.51.4.567.CrossRefPubMedPubMedCentral Mitchell SA, Thyssen M, Orchard TR, Jewell DP, Fleming KA, Chapman RW: Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study. Gut. 2002, 51 (4): 567-573. 10.1136/gut.51.4.567.CrossRefPubMedPubMedCentral
7.
go back to reference van Erpecum KJ, Smits SJ, van de Meeberg PC, Linn FH, Wolfhagen FH, vanBerge-Henegouwen GP, Algra A: Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology. 1996, 110 (5): 1503-1506. 10.1053/gast.1996.v110.pm8613056.CrossRefPubMed van Erpecum KJ, Smits SJ, van de Meeberg PC, Linn FH, Wolfhagen FH, vanBerge-Henegouwen GP, Algra A: Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology. 1996, 110 (5): 1503-1506. 10.1053/gast.1996.v110.pm8613056.CrossRefPubMed
8.
go back to reference Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, et al: HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens. 1999, 53 (5): 459-469. 10.1034/j.1399-0039.1999.530502.x.CrossRefPubMed Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, et al: HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens. 1999, 53 (5): 459-469. 10.1034/j.1399-0039.1999.530502.x.CrossRefPubMed
9.
go back to reference Karlsen TH, Boberg KM, Vatn M, Bergquist A, Hampe J, Schrumpf E, Thorsby E, Schreiber S, Lie BA: Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Genes Immun. 2007, 8 (3): 275-278. 10.1038/sj.gene.6364377.CrossRefPubMed Karlsen TH, Boberg KM, Vatn M, Bergquist A, Hampe J, Schrumpf E, Thorsby E, Schreiber S, Lie BA: Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Genes Immun. 2007, 8 (3): 275-278. 10.1038/sj.gene.6364377.CrossRefPubMed
10.
go back to reference Bittencourt PL, Palacios SA, Cancado EL, Carrilho FJ, Porta G, Kalil J, Goldberg AC: Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor alpha -308 promoter polymorphism. Gut. 2002, 51 (4): 609-610. 10.1136/gut.51.4.609.CrossRefPubMedPubMedCentral Bittencourt PL, Palacios SA, Cancado EL, Carrilho FJ, Porta G, Kalil J, Goldberg AC: Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor alpha -308 promoter polymorphism. Gut. 2002, 51 (4): 609-610. 10.1136/gut.51.4.609.CrossRefPubMedPubMedCentral
11.
go back to reference Neri TM, Cavestro GM, Seghini P, Zanelli PF, Zanetti A, Savi M, Podda M, Zuin M, Colombo M, Floreani A, et al: Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population. Dig Liver Dis. 2003, 35 (8): 571-576. 10.1016/S1590-8658(03)00274-3.CrossRefPubMed Neri TM, Cavestro GM, Seghini P, Zanelli PF, Zanetti A, Savi M, Podda M, Zuin M, Colombo M, Floreani A, et al: Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population. Dig Liver Dis. 2003, 35 (8): 571-576. 10.1016/S1590-8658(03)00274-3.CrossRefPubMed
12.
go back to reference Bowlus CL, Li CS, Karlsen TH, Lie BA, Selmi C: Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: Unique clinical and HLA associations. Liver Transplantation. 2010 Bowlus CL, Li CS, Karlsen TH, Lie BA, Selmi C: Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: Unique clinical and HLA associations. Liver Transplantation. 2010
13.
go back to reference Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV, Yawn BP, Dickson ER, Melton LJ: Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003, 125 (5): 1364-1369. 10.1016/j.gastro.2003.07.011.CrossRefPubMed Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV, Yawn BP, Dickson ER, Melton LJ: Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003, 125 (5): 1364-1369. 10.1016/j.gastro.2003.07.011.CrossRefPubMed
14.
go back to reference Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H: Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998, 33 (1): 99-103. 10.1080/00365529850166284.CrossRefPubMed Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H: Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998, 33 (1): 99-103. 10.1080/00365529850166284.CrossRefPubMed
15.
go back to reference Kaplan GG, Laupland KB, Butzner D, Urbanski SJ, Lee SS: The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol. 2007, 102 (5): 1042-1049. 10.1111/j.1572-0241.2007.01103.x.CrossRefPubMed Kaplan GG, Laupland KB, Butzner D, Urbanski SJ, Lee SS: The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol. 2007, 102 (5): 1042-1049. 10.1111/j.1572-0241.2007.01103.x.CrossRefPubMed
16.
go back to reference Kingham JG, Kochar N, Gravenor MB: Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. Gastroenterology. 2004, 126 (7): 1929-1930. 10.1053/j.gastro.2004.04.052.CrossRefPubMed Kingham JG, Kochar N, Gravenor MB: Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. Gastroenterology. 2004, 126 (7): 1929-1930. 10.1053/j.gastro.2004.04.052.CrossRefPubMed
17.
go back to reference Card TR, Solaymani-Dodaran M, West J: Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. J Hepatol. 2008, 48 (6): 939-944. 10.1016/j.jhep.2008.02.017.CrossRefPubMed Card TR, Solaymani-Dodaran M, West J: Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. J Hepatol. 2008, 48 (6): 939-944. 10.1016/j.jhep.2008.02.017.CrossRefPubMed
18.
go back to reference Lindkvist B, Benito de Valle M, Gullberg B, Bjornsson E: Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology. 2010, 52 (2): 571-577. 10.1002/hep.23678.CrossRefPubMed Lindkvist B, Benito de Valle M, Gullberg B, Bjornsson E: Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology. 2010, 52 (2): 571-577. 10.1002/hep.23678.CrossRefPubMed
19.
go back to reference Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan JY: Clinical profile of primary sclerosing cholangitis in Singapore. J Gastroenterol Hepatol. 2002, 17 (8): 908-913. 10.1046/j.1440-1746.2002.02835.x.CrossRefPubMed Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan JY: Clinical profile of primary sclerosing cholangitis in Singapore. J Gastroenterol Hepatol. 2002, 17 (8): 908-913. 10.1046/j.1440-1746.2002.02835.x.CrossRefPubMed
20.
go back to reference Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G: Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Eur J Gastroenterol Hepatol. 1996, 8 (7): 685-691.PubMed Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G: Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Eur J Gastroenterol Hepatol. 1996, 8 (7): 685-691.PubMed
21.
go back to reference Escorsell A, Pares A, Rodes J, Solis-Herruzo JA, Miras M, de la Morena E: Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. J Hepatol. 1994, 21 (5): 787-791. 10.1016/S0168-8278(94)80240-8.CrossRefPubMed Escorsell A, Pares A, Rodes J, Solis-Herruzo JA, Miras M, de la Morena E: Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. J Hepatol. 1994, 21 (5): 787-791. 10.1016/S0168-8278(94)80240-8.CrossRefPubMed
22.
go back to reference Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV: Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol. 2002, 97 (9): 2402-2407. 10.1111/j.1572-0241.2002.06019.x.CrossRefPubMed Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV: Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol. 2002, 97 (9): 2402-2407. 10.1111/j.1572-0241.2002.06019.x.CrossRefPubMed
23.
go back to reference Kochhar R, Goenka MK, Das K, Nagi B, Bhasin DK, Chawla YK, Vaiphei K, Singh K, Dilawari JB: Primary sclerosing cholangitis: an experience from India. J Gastroenterol Hepatol. 1996, 11 (5): 429-433. 10.1111/j.1440-1746.1996.tb00286.x.CrossRefPubMed Kochhar R, Goenka MK, Das K, Nagi B, Bhasin DK, Chawla YK, Vaiphei K, Singh K, Dilawari JB: Primary sclerosing cholangitis: an experience from India. J Gastroenterol Hepatol. 1996, 11 (5): 429-433. 10.1111/j.1440-1746.1996.tb00286.x.CrossRefPubMed
24.
go back to reference Takikawa H, Takamori Y, Tanaka A, Kurihara H, Nakanuma Y: Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients. Hepatol Res. 2004, 29 (3): 153-159. 10.1016/j.hepres.2004.03.006.CrossRefPubMed Takikawa H, Takamori Y, Tanaka A, Kurihara H, Nakanuma Y: Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients. Hepatol Res. 2004, 29 (3): 153-159. 10.1016/j.hepres.2004.03.006.CrossRefPubMed
25.
go back to reference Kamisawa T, Egawa N, Tsuruta K, Okamoto A, Funata N: Primary sclerosing cholangitis may be overestimated in Japan. J Gastroenterol. 2005, 40 (3): 318-319. 10.1007/s00535-004-1543-2.CrossRefPubMed Kamisawa T, Egawa N, Tsuruta K, Okamoto A, Funata N: Primary sclerosing cholangitis may be overestimated in Japan. J Gastroenterol. 2005, 40 (3): 318-319. 10.1007/s00535-004-1543-2.CrossRefPubMed
26.
go back to reference Kelly P, Patchett S, McCloskey D, Alstead E, Farthing M, Fairclough P: Sclerosing cholangitis, race and sex. Gut. 1997, 41 (5): 688-689. 10.1136/gut.41.5.688.CrossRefPubMedPubMedCentral Kelly P, Patchett S, McCloskey D, Alstead E, Farthing M, Fairclough P: Sclerosing cholangitis, race and sex. Gut. 1997, 41 (5): 688-689. 10.1136/gut.41.5.688.CrossRefPubMedPubMedCentral
27.
go back to reference Simsek H, Schuman BM: Inflammatory bowel disease in 64 black patients: analysis of course, complications, and surgery. J Clin Gastroenterol. 1989, 11 (3): 294-298. 10.1097/00004836-198906000-00010.CrossRefPubMed Simsek H, Schuman BM: Inflammatory bowel disease in 64 black patients: analysis of course, complications, and surgery. J Clin Gastroenterol. 1989, 11 (3): 294-298. 10.1097/00004836-198906000-00010.CrossRefPubMed
28.
go back to reference Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, Dassopoulos T, Schumm P, Gregory FJ, Griffiths AM, et al: Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006, 101 (5): 1012-1023. 10.1111/j.1572-0241.2006.00504.x.CrossRefPubMed Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, Dassopoulos T, Schumm P, Gregory FJ, Griffiths AM, et al: Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006, 101 (5): 1012-1023. 10.1111/j.1572-0241.2006.00504.x.CrossRefPubMed
29.
go back to reference Krieger N: Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992, 82 (5): 703-710. 10.2105/AJPH.82.5.703.CrossRefPubMedPubMedCentral Krieger N: Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992, 82 (5): 703-710. 10.2105/AJPH.82.5.703.CrossRefPubMedPubMedCentral
30.
go back to reference Weng X, Liu L, Barcellos LF, Allison JE, Herrinton LJ: Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization. Am J Gastroenterol. 2007, 102 (7): 1429-1435. 10.1111/j.1572-0241.2007.01215.x.CrossRefPubMed Weng X, Liu L, Barcellos LF, Allison JE, Herrinton LJ: Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization. Am J Gastroenterol. 2007, 102 (7): 1429-1435. 10.1111/j.1572-0241.2007.01215.x.CrossRefPubMed
31.
go back to reference Dobson AJ, Kuulasmaa K, Eberle E, Scherer J: Confidence intervals for weighted sums of Poisson parameters. Stat Med. 1991, 10 (3): 457-462. 10.1002/sim.4780100317.CrossRefPubMed Dobson AJ, Kuulasmaa K, Eberle E, Scherer J: Confidence intervals for weighted sums of Poisson parameters. Stat Med. 1991, 10 (3): 457-462. 10.1002/sim.4780100317.CrossRefPubMed
32.
go back to reference Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broome U, Schreiber S, Boberg KM: Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. Am J Gastroenterol. 2007, 102 (1): 115-121. 10.1111/j.1572-0241.2006.00928.x.CrossRefPubMed Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broome U, Schreiber S, Boberg KM: Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. Am J Gastroenterol. 2007, 102 (1): 115-121. 10.1111/j.1572-0241.2006.00928.x.CrossRefPubMed
33.
go back to reference Rabinovitz M, Gavaler JS, Schade RR, Dindzans VJ, Chien MC, Van Thiel DH: Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects. Hepatology. 1990, 11 (1): 7-11. 10.1002/hep.1840110103.CrossRefPubMed Rabinovitz M, Gavaler JS, Schade RR, Dindzans VJ, Chien MC, Van Thiel DH: Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects. Hepatology. 1990, 11 (1): 7-11. 10.1002/hep.1840110103.CrossRefPubMed
34.
go back to reference Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, Rolny P, Ryden BO, Tysk C, Wallerstedt S: Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology. 1991, 100 (5 Pt 1): 1319-1323.CrossRefPubMed Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, Rolny P, Ryden BO, Tysk C, Wallerstedt S: Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology. 1991, 100 (5 Pt 1): 1319-1323.CrossRefPubMed
35.
go back to reference Lundqvist K, Broome U: Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Dis Colon Rectum. 1997, 40 (4): 451-456. 10.1007/BF02258391.CrossRefPubMed Lundqvist K, Broome U: Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Dis Colon Rectum. 1997, 40 (4): 451-456. 10.1007/BF02258391.CrossRefPubMed
36.
go back to reference Moayyeri A, Daryani NE, Bahrami H, Haghpanah B, Nayyer-Habibi A, Sadatsafavi M: Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis. J Gastroenterol Hepatol. 2005, 20 (3): 366-370. 10.1111/j.1440-1746.2005.03727.x.CrossRefPubMed Moayyeri A, Daryani NE, Bahrami H, Haghpanah B, Nayyer-Habibi A, Sadatsafavi M: Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis. J Gastroenterol Hepatol. 2005, 20 (3): 366-370. 10.1111/j.1440-1746.2005.03727.x.CrossRefPubMed
37.
go back to reference Herrinton LJ, Liu L, Lewis JD, Griffin PM, Allison J: Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002. Am J Gastroenterol. 2008, 103 (8): 1998-2006. 10.1111/j.1572-0241.2008.01960.x.CrossRefPubMed Herrinton LJ, Liu L, Lewis JD, Griffin PM, Allison J: Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002. Am J Gastroenterol. 2008, 103 (8): 1998-2006. 10.1111/j.1572-0241.2008.01960.x.CrossRefPubMed
38.
go back to reference Hiatt RA, Kaufman L: Epidemiology of inflammatory bowel disease in a defined northern California population. West J Med. 1988, 149 (5): 541-546.PubMedPubMedCentral Hiatt RA, Kaufman L: Epidemiology of inflammatory bowel disease in a defined northern California population. West J Med. 1988, 149 (5): 541-546.PubMedPubMedCentral
Metadata
Title
The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population
Authors
Elaine Toy
Sripriya Balasubramanian
Carlo Selmi
Chin-Shang Li
Christopher L Bowlus
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2011
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-11-83

Other articles of this Issue 1/2011

BMC Gastroenterology 1/2011 Go to the issue